MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
MYL2 | Myosin, light chain 2, regulatory, cardiac, slow | Candidate cardiovascular disease genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
NGF | Nerve growth factor (beta polypeptide) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPPB | Natriuretic peptide B | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PDGFA | Platelet-derived growth factor alpha polypeptide | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFB | Platelet-derived growth factor beta polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PF4 | Platelet factor 4 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGAM1 | Phosphoglycerate mutase 1 (brain) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PGF | Placental growth factor | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G7 | Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
PLAT | Plasminogen activator, tissue | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Mixed |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PON2 | Paraoxonase 2 | Candidate cardiovascular disease genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PON3 | Paraoxonase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PROCR | Protein C receptor, endothelial | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
PROS1 | Protein S (alpha) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PRTN3 | Proteinase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PYGB | Phosphorylase, glycogen; brain | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
RETN | Resistin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SELE | Selectin E | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SELP | Selectin P (granule membrane protein 140kDa, antigen CD62) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
SELPLG | Selectin P ligand | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SERPINA1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA3 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINC1 | Serpin peptidase inhibitor, clade C (antithrombin), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINF2 | Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPING1 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
SHBG | Sex hormone-binding globulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TFPI | Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
TGFB1 | Transforming growth factor, beta 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
THBD | Thrombomodulin | Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
THBS1 | Thrombospondin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |